Pharma Mar (Spain) Probability of Future Stock Price Finishing Over 72.51
| PHM Stock | EUR 73.50 0.40 0.55% |
Pharma |
Pharma Mar Target Price Odds to finish over 72.51
The tendency of Pharma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above € 72.51 in 90 days |
| 73.50 | 90 days | 72.51 | about 15.59 |
Based on a normal probability distribution, the odds of Pharma Mar to stay above € 72.51 in 90 days from now is about 15.59 (This Pharma Mar SA probability density function shows the probability of Pharma Stock to fall within a particular range of prices over 90 days) . Probability of Pharma Mar SA price to stay between € 72.51 and its current price of €73.5 at the end of the 90-day period is about 1.53 .
Assuming the 90 days trading horizon Pharma Mar has a beta of 0.13 indicating as returns on the market go up, Pharma Mar average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pharma Mar SA will be expected to be much smaller as well. Moreover Pharma Mar SA has an alpha of 1.0009, implying that it can generate a 1.0 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Pharma Mar Price Density |
| Price |
Predictive Modules for Pharma Mar
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharma Mar SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pharma Mar Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharma Mar is not an exception. The market had few large corrections towards the Pharma Mar's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharma Mar SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharma Mar within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.00 | |
β | Beta against Dow Jones | 0.13 | |
σ | Overall volatility | 14.98 | |
Ir | Information ratio | 0.20 |
Pharma Mar Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharma Mar for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharma Mar SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharma Mar SA appears to be risky and price may revert if volatility continues | |
| Pharma Mar SA has accumulated 33.39 M in total debt. Pharma Mar SA has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharma Mar until it has trouble settling it off, either with new capital or with free cash flow. So, Pharma Mar's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharma Mar SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharma to invest in growth at high rates of return. When we think about Pharma Mar's use of debt, we should always consider it together with cash and equity. | |
| About 27.0% of the company outstanding shares are owned by corporate insiders |
Pharma Mar Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pharma Stock often depends not only on the future outlook of the current and potential Pharma Mar's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pharma Mar's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 18.1 M | |
| Cash And Short Term Investments | 201.9 M |
Pharma Mar Technical Analysis
Pharma Mar's future price can be derived by breaking down and analyzing its technical indicators over time. Pharma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pharma Mar SA. In general, you should focus on analyzing Pharma Stock price patterns and their correlations with different microeconomic environments and drivers.
Pharma Mar Predictive Forecast Models
Pharma Mar's time-series forecasting models is one of many Pharma Mar's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pharma Mar's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Pharma Mar SA
Checking the ongoing alerts about Pharma Mar for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pharma Mar SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pharma Mar SA appears to be risky and price may revert if volatility continues | |
| Pharma Mar SA has accumulated 33.39 M in total debt. Pharma Mar SA has a current ratio of 0.92, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharma Mar until it has trouble settling it off, either with new capital or with free cash flow. So, Pharma Mar's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharma Mar SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharma to invest in growth at high rates of return. When we think about Pharma Mar's use of debt, we should always consider it together with cash and equity. | |
| About 27.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Pharma Stock
Pharma Mar financial ratios help investors to determine whether Pharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharma with respect to the benefits of owning Pharma Mar security.